Skip to content
    ZKB logo

    ZKB

    Zurich, SwitzerlandFounded 1870
    www.zkb.chLinkedIn
    Biotech & Life SciencesClimate & EnergyFintechHardware & SemiconductorsHealthcare

    Zürcher Kantonalbank (ZKB) is a Swiss cantonal bank and one of Switzerland's most active venture capital investors, providing equity capital and convertible loans to innovative start-ups and scale-ups across sectors including biotech, cleantech, deep tech, healthcare, ICT, and fintech. Founded in 1870 and headquartered in Zurich, ZKB has supported over 250 start-ups with more than CHF 180 million in risk capital.

    Their most common stage is series-a (43% of deals). Average disclosed round size is $22.5M (across 18 rounds with reported amounts).

    Find people at ZKB on Goldilocks AI

    Portfolio

    55

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    DP

    Daniel Previdoli

    Head of Products, Services & Direct Banking

    Dr. Jürg Bühlmann

    Dr. Jürg Bühlmann

    Head of Corporate Customers

    Dr. Mario Crameri

    Dr. Mario Crameri

    Head of IT, Operations & Real Estate

    Dr. Martin Bardenhewer

    Dr. Martin Bardenhewer

    Chief Financial Officer

    FS

    Florence Schnydrig Moser

    Head of Private Banking, Deputy Chief Executive Officer

    HS

    Hjalmar Schröder

    Chief Risk Officer

    RR

    Roger Reist

    Head of Institutionals & Multinationals

    ST

    Susanne Thellung

    Head of Retail Clients

    UB

    Urs Baumann

    Chief Executive Officer (CEO)

    CS

    Christian Sarwa

    Managing Director Private Equity

    CB

    Christian Bader

    Senior equity analyst

    ID

    Iwan Deplazes

    Leiter Asset Management

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    58 investments
    CompanyRoundAmountDate
    UniSieve logoUniSieveSeries A$9MOct 2026
    Eleven Dynamics logoEleven DynamicsSeed—Feb 2025
    DePoly logoDePolySeed$23MJan 2025
    LLymphaticaSeries B—Oct 2024
    Lymphatica Medtech logoLymphatica MedtechSeries B—Oct 2024
    Somagenetix logoSomagenetixSeries A—Oct 2024
    MMicrocapsSeries A—Jun 2024
    MMicrocapsSeries A—Jan 2024
    Ikerian logoIkerianSeries A$6.2MJan 2024
    DePoly logoDePolySeed$23MJun 2023
    MMetacoUnknown$250MMay 2023
    Navignostics logoNavignosticsSeed—Nov 2022
    Qnami logoQnamiSeries A—May 2021
    SSynendosSeries A—Nov 2020
    Synendos Therapeutics logoSynendos TherapeuticsSeries A—Nov 2020
    LLocateeSeries A$4MMay 2020
    Nezasa logoNezasaGrowth$4.7MJan 2020
    MMetacoSeries A$17MJan 2020
    CCreoptixSeries C—Oct 2019
    AVAtronics logoAVAtronicsSeed—Jan 2019
    TOLREMO Therapeutics AG logoTOLREMO Therapeutics AGSeries A—Sep 2018
    Futurae logoFuturaeSeries A—Jan 2018
    TTolremoSeries A—Jan 2017
    Embotech logoEmbotechSeed—Jan 2017
    Ava logoAvaSeries A$9.7MNov 2016
    Page 1 of 3

    Top Co-Investors

    Verve Ventures22 shared
    Club degli Investitori7 shared
    High-Tech Gründerfonds7 shared
    Excellis6 shared
    Redalpine5 shared
    Founderful5 shared
    Kickfund5 shared
    Plug and Play Tech Center4 shared
    Swisscom Ventures3 shared
    BMW i Ventures3 shared
    private angel investors3 shared
    ACE & Company3 shared
    Credit Suisse Group AG3 shared
    EquityPitcher Ventures3 shared
    Airbus Ventures2 shared
    Porsche AG2 shared
    Volvo Cars Tech Fund2 shared
    imec.xpand2 shared
    Essential Capital2 shared
    Sunstone Life Science Ventures2 shared

    Last updated: 20 October 2026